Effects of sodium warfarin administered during pregnancy in mice.
D000014:Abnormalities, Drug-Induced; D000818:Animals; D001842:Bone and Bones / Q000002:abnormalities; D002971:Cleft Lip / Q000139:chemically induced; D002972:Cleft Palate / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D010064:Embryo Implantation; D004622:Embryo, Mammalian / Q000187:drug effects; D005260:Female; D005313:Fetal Death / Q000139:chemically induced / Q000517:prevention & control; D006470:Hemorrhage / Q000139:chemically induced; D051379:Mice; D008815:Mice, Inbred Strains; D010922:Placenta Diseases / Q000139:chemically induced; D011247:Pregnancy; D011517:Prothrombin Time; D012965:Sodium Chloride; D013997:Time Factors; D014812:Vitamin K / Q000494:pharmacology; D010837:Vitamin K 1 / Q000627:therapeutic use; D014859:Warfarin / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity*
D014812:Vitamin K; D012965:Sodium Chloride; D014859:Warfarin; D010837:Vitamin K 1